(PDF) Agonistic Monoclonal Antibodies Potentiate

Agonistic Monoclonal Antibodies Potentiate Tumorigenic and Invasive Activities of Splicing Variant of the RON Receptor Tyrosine Kinase

Cancer Biology and Therapy - United States

doi 10.4161/cbt.5.9.3073

Full Text

Abstract

Available in full text

Categories

Cancer Research

Molecular Medicine

Date

September 1, 2006

Authors

Publisher

Informa UK Limited

Related search

Autoinhibition of the Ron Receptor Tyrosine Kinase by the Juxtamembrane Domain

Cell Communication and Signaling

Molecular Biology

English

Tyrosine Kinase Receptor RON Functions Downstream of the Erythropoietin Receptor to Induce Expansion of Erythroid Progenitors

English

The RON Receptor Tyrosine Kinase Regulates IFN- Production and Responses in Innate Immunity

Journal of Immunology

English

Dorsal Ruffle Microdomains Potentiate Met Receptor Tyrosine Kinase Signaling and Down-Regulation

Journal of Biological Chemistry

Molecular Biology

English

Role of Macrophage-Stimulating Protein and Its Receptor, RON Tyrosine Kinase, in Ciliary Motility.

Journal of Clinical Investigation

English

Expression of the RON Receptor Tyrosine Kinase and Its Association With Gastric Carcinoma Versus Normal Gastric Tissues

Cancer Research

English

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-Ron ADC Zt/G4-Mmae

Molecular Cancer Therapeutics

Cancer Research

English

Induction of Cell Shape Changes Through Activation of the Interleukin-3 Common Β Chain Receptor by the RON Receptor-Type Tyrosine Kinase

Journal of Biological Chemistry

Molecular Biology

English

A Nuclear Variant of ErbB3 Receptor Tyrosine Kinase Regulates Ezrin Distribution and Schwann Cell Myelination

Journal of Neuroscience

English